Oncoimmunology

Oncoimmunology

肿瘤免疫学

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Oncoimmunology》是由Landes Bioscience出版社于2012年创办的英文国际期刊(ISSN: 2162-402X,E-ISSN: 2162-402X),该期刊长期致力于免疫学领域的创新研究,主要研究方向为ONCOLOGYIMMUNOLOGY-IMMUNOLOGY。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA未开放获取模式(OA占比0.0951...%),以发表免疫学领域等方向的原创性研究为核心(研究类文章占比96.49%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在114篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Oncoimmunology审稿周期约为 24 Weeks 。该刊近年未被列入国际预警名单,年发文量约114篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 114 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
IMMUNOLOGY 免疫学 ONCOLOGY 肿瘤学
2区 2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
IMMUNOLOGY 免疫学 ONCOLOGY 肿瘤学
2区 3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 30 / 181

83.7%

学科:ONCOLOGY SCIE Q1 44 / 322

86.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 28 / 181

84.81%

学科:ONCOLOGY SCIE Q1 51 / 322

84.32%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:12.8 SJR:2.345 SNIP:0.987
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 40 / 404

90%

大类:Medicine 小类:Immunology and Allergy Q1 30 / 233

87%

大类:Medicine 小类:Immunology Q1 34 / 236

85%

期刊发文

  • M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistance

    Author: Zheng, Naisheng; Wang, Tingting; Luo, Qin; Liu, Yi; Yang, Junyao; Zhou, Yunlan; Xie, Guohua; Ma, Yanhui; Yuan, Xiangliang; Shen, Lisong

    Journal: ONCOIMMUNOLOGY. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/2162402X.2023.2210959

  • Expression of OLR1 gene on tumor-associated macrophages of head and neck squamous cell carcinoma, and its correlation with clinical outcome

    Author: Zhang, Peng; Zhao, Yan; Xia, Xin; Mei, Song; Huang, Yixuan; Zhu, Yingying; Yu, Shuting; Chen, Xingming

    Journal: ONCOIMMUNOLOGY. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/2162402X.2023.2203073

  • Altered phenotypic and metabolic characteristics of FOXP3(+)CD3(+)CD56(+) natural killer T (NKT)-like cells in human malignant pleural effusion

    Author: Wang, Zi-Hao; Zhang, Pei; Peng, Wen-Bei; Ye, Lin-Lin; Xiang, Xuan; Wei, Xiao-Shan; Niu, Yi-Ran; Zhang, Si-Yu; Xue, Qian-Qian; Wang, Hao-Lei; Zhou, Qiong

    Journal: ONCOIMMUNOLOGY. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/2162402X.2022.2160558

  • Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer

    Author: Wang, Fulong; Lu, Shixun; Cao, Di; Qian, Juanjuan; Li, Cong; Zhang, Rongxin; Wang, Feng; Wu, Miaoqing; Liu, Yifan; Pan, Zhizhong; Wu, Xiaojun; Lu, Zhenhai; Ding, Peirong; Li, Liren; Lin, Junzhong; Catteau, Aurelie; Galon, Jerome; Chen, Gong

    Journal: ONCOIMMUNOLOGY. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/2162402X.2022.2161167

  • CARD9 deficiency promotes pancreatic cancer growth by blocking dendritic cell maturation via SLC6A8-mediated creatine transport

    Author: Tian, Cheng; Yuan, Huimin; Lu, Yi; He, Henghui; Li, Qing; Li, Senlin; Yang, Jian; Wang, Mengheng; Xu, Ruochen; Liu, Qian; Xiang, Ming

    Journal: ONCOIMMUNOLOGY. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/2162402X.2023.2204015

  • Gankyrin-mediated interaction between cancer cells and tumor-associated macrophages facilitates prostate cancer progression and androgen deprivation therapy resistance

    Author: Peng, Guang; Wang, Chao; Wang, Hongru; Qu, Min; Dong, Keqin; Yu, Yongwei; Jiang, Yuquan; Gan, Sishun; Gao, Xu

    Journal: ONCOIMMUNOLOGY. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/2162402X.2023.2173422

  • Suppression of prostate cancer and amelioration of the immunosuppressive tumor microenvironment through selective immunoproteasome inhibition

    Author: Koerner, Julia; Horvath, Dennis; Oliveri, Franziska; Li, Jun; Basler, Michael

    Journal: ONCOIMMUNOLOGY. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/2162402X.2022.2156091

  • Overcoming the resistance of hepatocellular carcinoma to PD-1/PD-L1 inhibitor and the resultant immunosuppression by CD38 siRNA-loaded extracellular vesicles

    Author: Deng, Jun; Ke, Hui

    Journal: ONCOIMMUNOLOGY. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/2162402X.2022.2152635